A carregar...

Breast Cancer Cell Lines Exhibit Differential Sensitivities to Microtubule-targeting Drugs Independent of Doubling Time

BACKGROUND: Microtubule-targeting agents (MTAs) are a mainstay in breast cancer treatment, yet patient responses differ. The underlying mechanisms of these differences are unknown. While MTAs are mitotic inhibitors, recent evidence highlights that non-mitotic effects of these drugs can contribute to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Anticancer Res
Main Authors: RISINGER, APRIL L., DYBDAL-HARGREAVES, NICHOLAS F., MOOBERRY, SUSAN L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4812601/
https://ncbi.nlm.nih.gov/pubmed/26504006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!